Recent Posts
Connect with:
Monday / August 15.
HomeminewsWorld First Dry Eye Registry Launched

World First Dry Eye Registry Launched

A world first dry eye registry, established in Sydney, will collect real-world data that clinicians can access to determine the long-term effectiveness and safety of treatments for dry eye.

The Save Sight Dry Eye Registry is the world’s first international, interdisciplinary dry eye registry. The registry’s international steering committee is led by The University of Sydney, Save Sight Institute Professor Stephanie Watson who said, “Clinical registries are beginning to play significant roles in healthcare decision making as they are able to collect real-world data over longer periods of time.”

The Save Sight Dry Eye Registry will allow clinicians to anonymously enter information into the registry that relates to multiple aspects of dry eye management, including the treatments used, individual patientreported outcomes and adverse reactions. This information will have positive outcomes for patients, clinicians, government health institutions and industry, specifically in the case of dry eye, because usually once drugs are approved for treatment, there is no postmarket surveillance.

Professor Fiona Stapleton from the School of Optometry and Vision Science, UNSW Sydney, said “The registry will help to understand the natural history of dry eye, to predict those patients who are at a higher risk of more severe disease and to tailor treatment for individual patients”.


The registry generates a patient education tool in the form of a patient graph. This assists clinicians to monitor and individualise patient treatments over time and allows the patient to become more involved in their treatment journey. Once established, the registry will be able to evaluate the clinical and patientreported outcomes from emerging therapies.

The registry also allows patients to complete online patient reported outcome questionnaires, such as the Ocular Surface Disease index, and clinicians to grade surface staining efficiently. “In my practice this has really helped me to determine which patients would be suitable for the newer therapies on the market, as these data may be needed for authority approval,” Professor Watson commented.

Request access at savesightregistries.org.


By agreeing & continuing, you are declaring that you are a registered Healthcare professional with an appropriate registration. In order to view some areas of this website you will need to register and login.
If you are not a Healthcare professional do not continue.